Abstract: Estimation of ventricular contractility is clinically important in diagnosing cardiac dysfunction in the critically ill. However, experimental assessment of indexes of ventricular contractility, such as the end-systolic pressure-volume relationship requires a highly invasive maneuver. This research describes the use of a previously validated cardiovascular system (CVS) model and identification process to evaluate the right-ventricle contractility as well as the right ventricular arterial coupling in septic shock. The results show good agreement with the gold-standard experimental assessment (conductance catheter method), and offer the potential to develop a model-based sensor to monitor the coupling in clinical realtime.
INTRODUCTION
When trying to assess ventricular systolic function, the estimation of ventricular contractility is known to be one of the key steps. Determination of ventricular function and contractility are clinically important in assessing and diagnosing cardiac and circulation dysfunction in critically ill patients. In particular, the differential diagnosis of septic shock, different from other causes of reduced cardiac output, is time critical and plays a major role in therapeutic decision making. Hence, such assessments can play a crucial role in the management of the critically ill.
Experimentally, the conductance catheter method allows for the determination of indexes of ventricular contractility, such as the end-systolic pressure-volume relationship (ESPVR). This method requires the recording of several pressurevolume loops during an induced preload reduction (caval occlusion), which is a highly invasive maneuver that disturbs the circulation further and would not be readily performed at the bedside for diagnostic purposes. It is easily seen that this procedure raises significant ethical and medical concerns.
Attempts to bypass the preload reduction have been suggested, such as "single-beat" methods (Brimioulle et al., 2003) , to avoid this potential risk. However, these studies are not completely reliable as they failed to detect the (known) contractility modifications induced by pharmacologic interventions (Lambermont et al., 2004) .
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Hence, an accurate replacement measure that is not further invasive would have clinically significant value.
Recently, mathematical models of the cardiovascular system (CVS) have been developed to assist medical professionals in differentiating and diagnosing CVS disturbances, such as pulmonary embolism, changes in positive end expiratory pressure (PEEP) or septic shock (Desaive et al., 2008 , Starfinger et al., 2008b , Starfinger et al., 2008d , Starfinger et al., 2008c , Starfinger et al., 2007 . These CVS models were able to capture all the fundamental CVS pressure and volume values and trends when compared to measured experimental data. The goal is to use the models and readily available clinical measurements to enable non-invasive patient specific monitoring and diagnosis.
The specific aim of this study is to use this previously described CVS model and identification process (Desaive et al., 2008 , Starfinger et al., 2008b , Starfinger et al., 2008d , Starfinger et al., 2008c to estimate the right ventricular contractility and the right ventricular-arterial coupling. Animal model data is used from a previously published porcine experiment of induced septic shock combined with continuous veno-venous hemofiltration (CVVH) therapy, which thus includes both septic shock and therapeutic dynamics (Lambermont et al., 2006) . Hence, this article compares a gold-standard clinical assessment (conductance catheter method) to a non-invasive model-based method.
This model-based approach offers a potentially reliable procedure to assess the right ventricle (RV) contractility, as well as the right ventricular-arterial coupling. This method thus opens up a new way to estimate the right ventricle systolic function in humans due to its preload independence.
Equally importantly, it offers the potential to develop a model-based sensor to monitor this metric in clinical realtime and thus use it in determining therapy, using only readily available clinical data.
MATERIALS AND METHODS
All experimental procedures and protocols used in this investigation were reviewed and approved by the Ethics Committee of the Medical Faculty of the University of Liege. They were performed in accordance with the Guide for the Care and Use of Laboratory Animals as adopted and promulgated by the U.S. National Institutes of Health (NIH Publication No.85-23, revised 1996) . The surgical preparation and experimental protocol are described in (Lambermont et al., 2006) with relevant details repeated here.
Experimental protocol and physiological measurements
Experiments were performed on 6 healthy pure pietran pigs of either sex weighing from 20 to 30kg. The animals were premedicated and anesthetized as described previously (Lambermont et al., 2006) . A micromanometer-tipped catheter (Sentron pressure-measuring catheter, Cordis, Miami, FL, U.S.A.) was inserted into the main pulmonary artery and a 14-mm diameter perivascular flow probe (Transonic Systems, Ithaca, NY, U.S.A.) was adjusted around the main pulmonary artery 2 cm downstream of the pulmonary valve. Left atrial pressure was measured with a micromanometer-tipped catheter and systemic blood pressure was monitored with a micromanometer-tipped catheter inserted into the descending thoracic aorta through the left femoral artery. A 7F, 12-electrode (8-mm interelectrode distance) conductance micromanometer-tipped catheter (CD Leycom, Zoetermeer, The Netherlands) was inserted through the RV infundibulum into the right ventricle and positioned so that all electrodes were in the RV cavity. A 6F Fogarty balloon catheter (Baxter Healthcare Corp., Oakland, Calif) was advanced into the inferior vena cava through a right femoral venotomy. Inflation of this balloon produced gradual preload reduction.
After a 30 min stabilization period, the animals received a 0.5mg/kg endotoxin infusion (Lipopolysaccharide from Escherichia Coli serotype 0127:B8; Sigma Chemical, St Louis, MO, USA) over a 30 min period (from T0 to T30). They underwent, from T60 onwards, a zero-balance continuous veno-venous hemofiltration at a rate of 45ml/kg/h. A 0.7m 2 large pore (78 Å) membrane with a cutoff of 80kDa (Sureflux FH 70, Nipro, Osaka, Japan) and a hemofiltration device Baxter BM 25-BM 14 (Baxter Health Care, Munich, Germany) were used. Ultrafiltrate was replaced in the postdilution mode by a bicarbonate-buffered hemofiltration fluid (Na + : 150mM, K + : 3mM, bicarbonate: 30mM) at a temperature of 37°C.
Hemodynamic data included pulmonary artery pressure (PAP) wave, pulmonary blood flow wave, left atrial pressure, systemic arterial pressure, heart rate, RV pressure, RV volume and RV pressure-volume (PV) loops. These parameters were monitored online and recorded every 30 minutes from T0 to T240 during a short apneic phase and stored for subsequent analysis. All analog signals were sampled at 200 Hz and continuously converted to digital form with an appropriate system (Codas, DataQ Instruments Inc., Akron, OH, USA).
Data analysis
A four-element windkessel model (WK4) was used to analyze the flow conditions in the pulmonary circulation throughout the experimental process. In this model ( Figure  1 ), a resistor (R 2 ) represents the resistive properties of the pulmonary vasculature. A capacitor (C) is placed parallel to R 2 and describes the compliant properties of the pulmonary arterial tree. A second resistor (R 1 ) is placed at the input of the circuit and reflects the characteristic impedance of the proximal pulmonary stem. Finally, an inductance (L) is added in series to accounts for the inertial properties of the blood. The arterial elastance ( ), which reflects RV afterload, was calculated from the WK4 parameters with the formula (Sunagawa et al., 1984 ):
where T s and T d are respectively the systolic and diastolic intervals, while R 1 , R 2 and C can be estimated using a classical, well accepted procedure described previously (Lambermont et al., 1999) .
Right ventricular PV loops were obtained using the conductance catheter method. The RV end-systolic elastance ( ) was determined during a rapid inferior vena cava occlusion maneuver (Dickstein et al., 1995) . Preload was reduced by progressive inflation of the Fogarty balloon in the inferior vena cava for no more than 10s to avoid the intervention of a baroreflex mechanism. End-systolic PV relationship was determined by fitting a straight line through the end-systolic PV points.
To assess the right ventricular-arterial coupling, the / ratio was computed. Under normal operating conditions, the right ventricle operates at a maximum efficiency and a submaximal stroke work ( /( > 1), while uncoupling occurs when / < 1 (Fourie et al., 1992 , Lambermont et al., 2003a .
CVS Model
The CVS model is a lumped parameter model of 6-8 elastic chambers with two active chambers for the left and right ventricles. The original model has been extended recently (Desaive et al., 2008 , Smith et al., 2004 , Smith et al., 2006 , Starfinger et al., 2008a , Starfinger et al., 2008d , Starfinger et al., 2008c and an overview of the 8 chambers version used in this research is given in Figure 2 . Each chamber is characterized by the flow in and out of the chamber, the pressure up-and downstream, the resistances of the heart valves, and inertia of the blood. The CVS model uses the classical concept of time varying elastance proposed by Suga et al. (Suga et al., 1973) to simulate the cardiac muscle activation. More specifically, the upper and lower limits of the elastance are defined by the end-systolic pressure-volume relationship (ESPVR) and enddiastolic pressure-volume relationship (EDPVR) (Burkhoff et al., 1988) . By combining the ESPVR and EDPVR an equation relating the ventricular pressure (P) to the ventricular volume (V):
where P 0 , V 0 and λ are respectively, the pressure gradient and the volume at zero pressure and the curvature, while E esrvf is the RV end-systolic elastance and e(t) is the activation function ( Figure 3 ) that accounts for ventricular activation (Smith et al., 2004 , Smith et al., 2006 .
Fig. 3. Plot of the activation function e(t).
The pulmonary artery is also described by a simple pressurevolume relationship:
where P pa and V pa denote the pulmonary artery pressure and volume respectively. E pa is the arterial elastance. Using Equations 2 and 3, the identified right-ventricular coupling can be computed as the ratio / .
Integral-based parameter identification
The parameter identification method used in this research has already been shown to rapidly and accurately identify virtually the entire parameter set in the presence of significant measurement noise (Desaive et al., 2008 , Hann et al., 2006 , Starfinger et al., 2008a , Starfinger et al., 2008d , Starfinger et al., 2008c ) and limited measurements (Hann et al., 2009 , Hann et al., 2010 . It has been successfully tested on experimental animal models of pulmonary embolism (Starfinger et al., 2007) , PEEP titrations and volume therapy decision support (Starfinger et al., 2008d , Starfinger et al., 2008c , and septic shock experiments (Desaive et al., 2008 , Starfinger et al., 2008b .
During the identification process only the systolic and diastolic values of both ventricles volumes, as well as pressure in the aorta and in the pulmonary artery are used. It is important to note that in this study it was not intended to perfectly match the pressure and volume waveform shapes, but only the minimum (diastolic) and maximum (systolic) values. Hence, it seeks to capture the primary, clinically relevant dynamics for decision support at the bedside, rather than a potentially more perfect physiological picture. Furthermore, important improvements of the identification process have been made recently. In particular, the maximum and minimum volumes are no longer required, while maintaining the same level of identification and diagnostic trend accuracy reported in the prior studies cited (Hann et al., 2009 , Hann et al., 2010 .
In this model-based approach, the elastance defined in Equation 2 ( ) is directly identified from the experimental data using the model and the identification method. The arterial compliance (C pa ) and consequently the arterial elastance (E pa ) in Equation 3 is evaluated from experimental data with the classical approximation (Chemla et al., 1998 , Zhu et al., 1995 
where PP a denotes the artery pulse pressure and SV the stroke volume.
The arterial elastance calculated from the Windkessel model's parameters ( ) reflects the afterload. In the model, two parameters may capture this effect. First E pa defined in equation 4. However, truer to the situation, the mean pulmonary inflow resistance (Rpulin) identified with the model-based identification process, captures this effect as well (Lankhaar et al., 2006 , Lankhaar et al., 2008 . Moreover, as it is identified from the data, it may better represent the afterload for each subject compared to the approximation in Equation 4.
Hence, this study examines both a non-invasive model-based measure for ( / ), comparing both / and / . The goal is to obtain a non-invasive measure that best captures the gold-standard measure, and is also physiologically representative or relevant. In this case, there are thus two possibilities based on the physiology and how the model captures and approximates those physiological dynamics.
3. RESULTS Figure 4 shows the mean (model-based) right ventricle endsystolic elastance ( ) over all pigs during the experiment. This elastance is identified during the identification process and the value depends on the assumed volume at zero pressure (V 0 ) for the ventricle used in the model. For reasons of simplicity, this value is assumed to be zero (V 0 =0 ml) during the identification. However, can easily be adjusted for a different and probably more realistic V 0 as can be seen in Figure 4 where is depicted for V 0 =0 ml and V 0 =23 ml, which spans a realistic range.
Fig. 4. Mean identified right ventricle elastance (
) for all 5 analyzed pigs during the endotoxic shock experiment These identified are compared with previously reported values obtained for the same experimental data (Lambermont et al., 2006) . Figure 5 shows that the values and the resulting correlation trends match well (R 2 = 0.69) with a trend line defined: = 0.22 * + 0.45. This line does not pass through the origin probably due to experimental errors on and no identification of V 0 from the data. To compare the right ventricular-arterial coupling, we computed the identified coupling with / . Even if the simulated and experimental elastances match accurately, we found a very poor correlation for the coupling (R 2 = 0.04). For the / estimate, Figure 6 shows the time evolution of Rpulin and . Both trends match closely. 
DISCUSSION
The major findings of this research are twofold. First, the results that were obtained previously (Lambermont et al., 2006) are confirmed using the extended CVS model and parameter identification process. In Figure 7 it can be seen how hemofiltration, which starts at 60 min into the experiment, is able to prevent RV-vascular uncoupling (ratio < 1.0). This effect or behaviour is commonly observed during the late phases of endotoxic shock (Lambermont et al., 2003b) . In particular, the data shows that in the early phases of endotoxic shock, RV-vascular coupling is preserved by an increase in RV contractility ( ) as seen in Figure 4 . During the later stages and with CVVH, RV-vascular coupling is preserved where a decrease in pulmonary vascular resistance (Rpulin), as seen in Figure 6 , is suggested to be the main reason for this result (Lambermont et al., 2006) . These results allow for a better understanding of the mechanisms of RV dysfunction during septic shock and thus have the potential to lead to more effective therapies and strategies for treating myocardial depression in septic shock.
Second, the results of this research present an important clinical outcome. They show that it is possible to relatively accurately calculate the right ventricular-arterial coupling without the need of an invasive preload reduction by doing this model-based approach. As mentioned previously, the assessment of RV contractility requires the occlusion of the vena cava which raises obvious ethical and medical concerns. This model-based approach uses only a clinically realistic and minimal data set.
The RV end-systolic elastance is directly identified from the model and the available experimental data. Using only minimum and maximum values of arterial pressure and ventricular volume, the identification process gives an accurate measure of the elastance. Moreover, using the pulmonary resistance (Rpulin) to characterize the RV afterload, there is no need to evaluate the arterial elastance by means of the parameters of the windkessel model, which has the main drawback of needing accurate pressure and flow waveforms (Lambermont et al., 1998) .
Although a good correlation was found between the experimental and the identified measures of the preload and the afterload, the resulting ratio assessing ventricular-arterial coupling shows a comparatively poor correlation. As it is defined by the ratio of the preload to the afterload, there can be a propagation of the experimental errors. However, defining the RV ventricular-arterial coupling with the modelbased R pulin value and ratio defined, / , a good agreement is found with the data from (Lambermont et al., 2006) , but with a significantly smaller data set and no preload reduction.
This outcome shows the importance to use patient-specific identified parameters instead of parameters estimated from the experimental data. This model-based approach thus offers potentially a new and more reliable procedure to assess the right ventricle contractility, as well as the right ventriculararterial coupling. It also defines a new model-based metric ( / ) that should be able, with adequate calibration, to monitor coupling in clinical real-time and thus be used in determining therapy. In particular, because every element of this new metric is available at the bedside and can be assessed effectively continuously, it is a metric that can be used at any point in time the clinician wishes to assess, diagnose, and monitor patient condition.
CONCLUSIONS
This study shows the ability of the CVS model to adequately and realistically capture the impact of pressure-volume changes during endotoxic shock and with CVVH. Comparable results to previously reported studies are obtained when analyzing the RV-vascular coupling, further validating the here presented methods and approach. This research thus increases our confidence in the clinical applicability and validity of this overall diagnostic monitoring approach.
